Showing results (1141-1150 of 1,858) with videos related to

Sort By:
Pageof 186
Biophysical Journal|August 18, 2010
RhoA regulates calcium-independent periodic contractions of the cell cortexNancy Costigliola, Maryna T Kapustina, Gabriel E Weinreb, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|June 18, 2009
Effectiveness of multi-channel unilateral cochlear implants for profoundly deaf children: a systematic reviewM Bond, J Elston, S Mealing, et al.
Lancet (London, England)|August 11, 1979
Relationship of oestrogen-receptor status to survival in breast cancerH M Bishop, R W Blamey, C W Elston, et al.
Respirology (Carlton, Vic.)|November 25, 2016
Physiological markers of exercise capacity and lung disease severity in cystic fibrosisLaurie Smith, Charles C Reilly, Victoria MacBean, et al.
British Journal of Cancer|September 1, 1989
Results from a seven-year programme of breast self-examination in 89,010 womenA P Locker, J Caseldine, A K Mitchell, et al.
Human Genetics|January 1, 1984
Coagulation factor XIII: a useful polymorphic genetic markerJ B Graham, C J Edgell, H Fleming, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2005
High heritability of ambulatory blood pressure in families of East African descentMurielle Bochud, Pascal Bovet, Robert C Elston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?Denise Daley, Wendi Morgan, Susan Lewis, et al.
British Journal of Haematology|November 9, 2019
Increased frequency of CD4<sup>+</sup> PD-1<sup>+</sup> HLA-DR<sup>+</sup> T cells is associated with disease progression in CLLLauren Elston, Chris Fegan, Robert Hills, et al.
JCO Oncology Practice|March 21, 2020
Comparative Safety and Health Care Expenditures Among Patients With Chronic Myeloid Leukemia Initiating First-Line Imatinib, Dasatinib, or NilotinibAshley L Cole, William A Wood, Benyam Muluneh, et al.
Pageof 186